T1	Participants 62 97	ischaemic ulcers of the lower limb.
T2	Participants 100 168	Scandinavian-Polish placebo controlled, randomised multicenter study
T3	Participants 301 394	103 patients with ischaemic ulcers who were randomised to receive active treatment or placebo
